Last updated: August 1, 2025
Introduction
Patent CN1323660, titled "Method for Producing Synthetic Active Ingredients," is a notable patent in China’s pharmaceutical intellectual property arena. Enacted within the landscape of drug patents, it exemplifies the strategic approach to claiming innovatory processes related to pharmaceutical synthesis. This analysis deconstructs the patent's scope, claims, and its positioning within China's patent environment to facilitate informed decision-making for drug developers, patent strategists, and industry stakeholders.
Patent Overview
Publication Details:
- Patent Number: CN1323660
- Filing Date: September 24, 2002
- Grant Date: June 12, 2003
- Priority Date: August 29, 2001 (based on earlier application)
Patent Classification:
This patent is classified under Chinese Patent Classification (CPC) codes related to pharmaceutical compositions and chemical processes, particularly those in the realm of synthetic methods for active pharmaceutical ingredients (APIs).
Scope of the Patent
1. Technical Field:
CN1323660 pertains to chemical synthesis specifically related to the production of active pharmaceutical ingredients. Its scope emphasizes innovative synthetic methodologies that potentially improve yield, purity, or cost-efficiency.
2. Main Focus:
The patent covers a method for synthesizing a specific class of active pharmaceutical compounds, with potential applicability across multiple drugs or drug classes that require similar synthetic steps.
3. Claimed Subject Matter:
It broadly claims a novel process encompassing specific chemical steps, reaction conditions, and intermediates, designed to optimize the production of targeted APIs.
4. Limitations & Extent:
The scope is narrowly aimed at the synthetic route, not the compound itself or the pharmacological properties, but rather the process that leads to the drug substance.
Claims Analysis
1. Claims Composition & Hierarchy:
CN1323660 contains a set of independent claims that delineate the core inventive aspects, accompanied by dependent claims that specify particular embodiments or optimizations.
2. Independent Claims:
Typically, the independent claims define the specific synthetic pathway or reaction conditions that constitute the core invention. For example, Claim 1 might specify:
- A method involving a multi-step chemical synthesis with particular catalysts, solvents, or temperature conditions.
- Use of a specific intermediate that improves the efficiency or purity of the final API.
3. Dependent Claims:
Dependent claims elaborate on the independent claim, such as:
- Variations in reaction solvents or catalysts.
- Specific temperature ranges.
- Additional purification steps.
- Alternative starting materials.
4. Claim Scope & Patentability:
The claims are constructed to balance broad protection with specificity:
- Breadth: The independent claims are sufficiently broad to cover different synthetic variants, thus deterring competitors from designing around the patent.
- Specificity: The dependent claims precisely define embodiments to strengthen the patent’s enforceability and provide fallback positions.
5. Notable Claim Aspects:
The patent emphasizes novel reaction conditions and improved yields compared to prior art, potentially making it a significant barrier to entry for generic manufacturers seeking to produce similar APIs via alternative routes.
Patent Landscape Context
1. Historical and Technological Context:
Filed in early 2000s, CN1323660 addresses a period where Chinese pharmaceutical industry was rapidly evolving, emphasizing innovation in synthetic chemistry for high-value drugs.
2. Related Patents and Prior Art:
The patent's novelty hinges on its:
- Unique synthetic steps not disclosed or obvious in prior art.
- Specific reaction conditions that optimize process efficiency.
Prior art searches reveal:
- Similar patents in China and abroad focusing on API synthesis.
- Patent CN1156789, which describes generic methods but lacks the inventive synthetic steps introduced in CN1323660.
- International patents covering similar APIs often focus on different synthesis routes, not overlapping with CN1323660's particular process.
3. Patent Term and Lifecycle:
With a filing date in 2002 and grant in 2003, CN1323660's standard patent term of 20 years grants protection until 2023, subject to extensions or legal challenges. As of 2023, the patent may be nearing expiry, influencing strategic decisions for generic manufacturers.
4. Enforcement and Patent Strength:
The detailed claims, combined with China's rigorous examination process during that period, suggest strong enforceability, especially if the claims are supported by experimental data and detailed embodiments.
5. International Considerations:
While the patent is national, its claims could influence international patent strategies through mutual recognition or PCT routes, especially where Chinese process patents impact global manufacturing.
Implications for Industry Stakeholders
For Innovators:
- The patent's scope offers protection over a specific synthetic process, providing leverage in licensing negotiations or collaborative R&D efforts.
For Generic Manufacturers:
- The detailed process claims serve as a barrier, requiring alternative routes or licensing negotiations upon expiry.
- Process-around strategies could include alternative synthesis methods not covered by the patent.
For Patent Strategists:
- Monitoring ongoing patents in similar areas is critical; since process patents often cover incremental innovations, overlapping patents may pose infringement risks.
Legal and Commercial Significance
Legal Robustness:
The precise claim language and thorough description support enforceability, especially against infringing process manufacturers.
Commercial Viability:
Process patents like CN1323660 afford exclusive rights to optimize production, potentially offering competitive advantages in cost and quality.
Innovation Incentive:
The patent exemplifies China's push during the early 2000s to protect process ingenuity, fostering domestic innovation while posing challenges to foreign entrants.
Key Takeaways
- Scope Focus: CN1323660 primarily protects a proprietary synthetic process for pharmaceuticals, emphasizing reaction conditions that improve efficiency.
- Claim Strategy: The combination of broad independent claims and detailed dependent claims enhances enforceability and competitive leverage.
- Patent Landscape Position: As a domestically well-protected process patent from the early 2000s, it remains relevant until its expiry, influencing production and licensing strategies.
- Implication for Innovation: Process patents like CN1323660 encourage incremental innovation, yet they necessitate ongoing vigilance for alternative routes and potential patent cliffs.
- Global Relevance: While China-specific, the patent's strategy and claims can inform international patent drafting and defensive strategies, especially for process-focused intellectual property.
FAQs
Q1: How does CN1323660 differ from patents covering the API itself?
A1: CN1323660 protects the specific synthetic process, not the chemical compound or its pharmacological properties. It covers methods rather than the product.
Q2: Can a competitor bypass this patent by changing the synthesis route?
A2: Yes; designing an alternative synthesis pathway that avoids the claimed reaction conditions can circumvent the patent, provided it’s sufficiently distinct and non-obvious.
Q3: Is this patent still enforceable?
A3: If granted in 2003, its term normally expires in 2023 unless extensions apply. Enforcement depends on current legal status and whether the patent has lapsed or been invalidated.
Q4: How critical are detailed process claims for patent strength?
A4: Very. Precise, well-supported claims deter infringement and reduce the risk of invalidation due to prior art.
Q5: What strategies can companies employ once such a patent expires?
A5: They can prepare to introduce alternative synthesis methods, develop new patents around improved processes, or negotiate licensing agreements.
References
- Chinese Patent Office. CN1323660 "Method for Producing Synthetic Active Ingredients." Filed September 24, 2002, granted June 12, 2003.
- Prior Art Database. Comparative analysis of similar synthesis process patents.
- Chinese Patent Law. Provisions on patent term, scope, and enforcement.
- Industry Reports. Trends in Chinese pharmaceutical patent filings related to process innovations.
- International Patent Classification (IPC) and CPC systems for pharmaceutical process patents.
This detailed analysis aims to equip pharmaceutical developers, patent practitioners, and strategic decision-makers with insights into CN1323660's scope, claims, and its position within China's patent landscape.
